Bette Caan to Polymorphism, Genetic
This is a "connection" page, showing publications Bette Caan has written about Polymorphism, Genetic.
Connection Strength
1.017
-
Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol Biomarkers Prev. 2009 Dec; 18(12):3384-8.
Score: 0.082
-
MSH6 G39E polymorphism and CpG island methylator phenotype in colon cancer. Mol Carcinog. 2009 Nov; 48(11):989-94.
Score: 0.082
-
Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat Res. 2009 Jan 15; 660(1-2):12-21.
Score: 0.076
-
The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer. Genes Chromosomes Cancer. 2008 Oct; 47(10):835-44.
Score: 0.076
-
Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut. 2009 May; 58(5):661-7.
Score: 0.074
-
Transcription factor 7-like 2 polymorphism and colon cancer. Cancer Epidemiol Biomarkers Prev. 2008 Apr; 17(4):978-82.
Score: 0.073
-
Polymorphisms in insulin-related genes predispose to specific KRAS2 and TP53 mutations in colon cancer. Mutat Res. 2006 Mar 20; 595(1-2):117-24.
Score: 0.064
-
Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer. Nutr Cancer. 2006; 55(1):35-43.
Score: 0.063
-
Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1350-2.
Score: 0.060
-
Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer. 2004 Sep 20; 111(5):750-6.
Score: 0.057
-
Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2004 Jul; 13(7):1206-14.
Score: 0.056
-
MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 2004 Feb; 13(2):285-92.
Score: 0.055
-
Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Mol Nutr Food Res. 2013 Apr; 57(4):721-34.
Score: 0.025
-
Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women. Nutr Cancer. 2011; 63(3):357-66.
Score: 0.022
-
Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors. Nutr Cancer. 2010; 62(4):436-42.
Score: 0.021
-
Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics and survival. Int J Cancer. 2007 May 15; 120(10):2226-32.
Score: 0.017
-
Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers. Cancer Epidemiol Biomarkers Prev. 2006 Apr; 15(4):744-9.
Score: 0.016
-
Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Cancer Epidemiol Biomarkers Prev. 2005 Dec; 14(12):2936-42.
Score: 0.016
-
Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 2005 Nov; 14(11 Pt 1):2509-16.
Score: 0.015
-
Insulin-like growth factor pathway polymorphisms associated with body size in Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1802-9.
Score: 0.015
-
Energy balance, insulin-related genes and risk of colon and rectal cancer. Int J Cancer. 2005 May 20; 115(1):148-54.
Score: 0.015
-
Interactions of peroxisome proliferator-activated receptor {gamma} and diet in etiology of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1224-9.
Score: 0.015
-
Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control. 2004 Nov; 15(9):863-72.
Score: 0.014
-
NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 1998 Dec; 7(12):1079-84.
Score: 0.010